文献速递免疫规划

腹腔B-1b和B-2 B细胞在Prevnar-13接种后提供针对3型肺炎链球菌感染的长期保护,且在镰状细胞病小鼠中缺陷

Peritoneal B-1b and B-2 B-cells confer long-term protection from pneumococcal serotype 3 infection after vaccination with Prevnar-13 and are defective in sickle cell disease mice.
PubMed 文献 · Vaccine · 2017-05-22

研究用Prevnar-13间隔三周免疫野生型(WT)和镰状细胞病(SCD)小鼠三次,14周后分离腹腔B-1a、B-1b和B-2细胞过继转移至Rag-/-受体,再用3型肺炎链球菌攻击。接受WT来源B-1b或B-2细胞的受体存活,接受WT来源B-1a细胞的受体死亡;接受SCD来源任一亚型细胞的受体均死亡。

要点

  • WT小鼠B-1b或B-2细胞过继转移使受体在3型肺炎链球菌攻击后存活。
  • WT小鼠B-1a细胞过继转移的受体在攻击后死亡。
  • SCD小鼠B-1a、B-1b或B-2细胞过继转移的受体均死亡。

核心结论

  • Prevnar-13接种后B-1b和B-2细胞均似乎提供长期免疫,但这两个亚型在SCD小鼠中均功能缺陷。

研究设计与样本

  • 野生型(WT)和镰状细胞病(SCD)小鼠间隔三周接种Prevnar-13三次,14周后分离腹腔B-1a、B-1b和B-2细胞(5×10^4个)腹腔过继转移至Rag-/-受体,一周后以10^3 CFU的3型肺炎链球菌腹腔攻击。

主要发现

  • 接受WT小鼠B-1b或B-2细胞的受体小鼠在攻击后存活,接受WT小鼠B-1a细胞的受体小鼠死亡。
  • 接受SCD小鼠B-1a、B-1b或B-2细胞的受体小鼠在攻击后均死亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Long-term immunity after inoculation with the pneumococcal conjugate vaccine (Prevnar-13) is impaired in sickle cell disease (SCD) mice. We sought to determine which B-cell subsets are defective in SCD mice after vaccination with Prevnar-13, yet confer long-term immunity in wild-type (WT) mice. We vaccinated WT and SCD mice three times at three week intervals with Prevnar-13. Fourteen weeks later, 5∗104 cells of isolated peritoneal B-1a, B-1b, and B-2 cells were harvested and intraperitoneally transferred to Rag -/- recipients. A week later recipients were intraperitoneally challenged with 103CFU of Streptococcus pneumoniae (serotype 3). Recipient mice that received either B-1b or B-2 B-cells from WT mice survived challenge, whereas mice that received B-1a cells died. Recipient mice that received B-1a, B-1b, or B-2 cells from SCD mice died after challenge. Both B-1b and B-2 cells appear to confer long-term immunity after Prevnar-13 vaccination, yet neither subset functions properly in SCD mice.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Cotte C, Szczepanek SM. Peritoneal B-1b and B-2 B-cells confer long-term protection from pneumococcal serotype 3 infection after vaccination with Prevnar-13 and are defective in sickle cell disease mice. Vaccine. 2017. PMID: 28545925. doi:10.1016/j.vaccine.2017.05.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。